Oral oseltamivir reduces febrile illness in patients considered at high risk of influenza complications
- 31 October 2001
- journal article
- Published by Elsevier in International Congress Series
- Vol. 1219, 807-811
- https://doi.org/10.1016/s0531-5131(01)00359-4
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000
- Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung DiseaseAnnals of Internal Medicine, 1999